Positions
- Professor of Surgery
-
Division of Pediatric Surgery
ÌÇÐÄÊÓÆµ of Medicine
- Attending Surgeon, Pediatric Surgery Service
-
Texas Children's Hospital
- Program Director, General Surgery Residency - Research Track
-
ÌÇÐÄÊÓÆµ of Medicine
Addresses
- Texas Children's Hospital (Clinic)
-
Clinical Care Center
6701 Fannin Street
Houston, TX, 77030
United States
Phone: (832) 822-3135
Education
- Pediatric Surgery Residency from ÌÇÐÄÊÓÆµ Of Medicine
- 01/2011 - Houston, TX, United States
- General Surgery Residency from ÌÇÐÄÊÓÆµ Of Medicine
- 01/2009 - Houston, TX, United States
- M.D. from Emory University School Of Medicine
- 01/2001 - Atlanta, GA, United States
- B.A. from Emory University
- 01/1997 - Atlanta, GA, United States
- B.S. from Emory University
- 01/1997 - Atlanta, GA, United States
Certifications
- Board Certified - Pediatric Surgery
- American Board of Surgery
- Board Certified - General Surgery
- American Board of Surgery
Honors & Awards
- Norton Rose Fulbright Faculty Excellence Award for Teaching & Evaluation
- ÌÇÐÄÊÓÆµ of Medicine
- 2020 Top Doctor: Pediatric Surgery
- Houstonia Magazine
- Michael E. DeBakey Distinguished Service Award
- Michael E. DeBakey Department of Surgery
Professional Interests
- Pediatric surgical oncology
- Neuroblastoma
Professional Statement
Dr. Sanjeev A. Vasudevan is committed to providing the finest patient-oriented pediatric surgical care with special attention to the surgical needs of children with cancer and the needs of their families. This dedication combines education and training, advanced research, and the development of newer and better treatments and procedures.
Dr. Vasudevan’s laboratory research focuses on the validation of potential therapeutic targets found in pediatric solid tumors and cancer, in particular neuroblastoma. During his postdoctoral training in the Texas Children’s Cancer Center with Drs. Jed G. Nuchtern and Jianhua Yang, Dr. Vasudevan cloned two novel genes, NDSP and DUSP26, which were found to be specifically expressed in neuroblastoma and play critical roles in neuroblastoma tumor growth and chemosensitivity.
Dr. Vasudevan is furthering this work as the principal investigator of a research project that focuses on the function and regulation of both the p53 and MYCN pathways in neuroblastoma. His lab uses techniques such as retroviral-induced shRNA inhibition of protein expression, real-time PCR, chromatin immunoprecipitation, recombinant protein purification, in vitro proliferation and cytotoxicity assays, orthotopic mouse models of neuroblastoma, and in vivo bioluminescence imaging for molecular target validation. Dr. Vasudevan’s lab research hopes to validate multiple targets in order to find novel and less toxic therapeutic agents to improve outcomes in neuroblastoma.
Videos
Selected Publications
-
Vasudevan SA, Shang X, Chang S, Ge N, Diaz-Miron JL, Russell HV, Hicks MJ, Ludwig AD, Wesson CL, Burlingame SM, Kim ES, Khan J, Yang J, Nuchtern JG. " " Mol. Cancer Ther.. 2009 Aug ; 8 (8) : 2478-89.
Pubmed PMID: . -
Hassan SF, Mathur S, Magliaro TJ, Larimer EL, Ferrell LB, Vasudevan SA, Patterson DM, Louis CU, Russell HV, Nuchtern JG, Kim ES. " " J. Pediatr. Surg.. 2012 Jun ; 47 (6) : 1261-6.
Pubmed PMID: . -
Fallon SC, Redell MS, El-Bietar J, Lopez ME, Vasudevan SA, Brandt ML. " " J. Pediatr. Surg.. 2013 Feb ; 48 (2) : 436-40.
Pubmed PMID: . -
Wulkan ML, Vasudevan SA. " " J. Pediatr. Surg.. 2001 Aug ; 36 (8) : 1234-6.
Pubmed PMID: .
Memberships
- American Association for Cancer Research
- American College of Surgeons
- Phi Beta Kappa
- Society of University Surgeons
to edit your profile